相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Platelet-Rich Plasma Extract Prevents Pulmonary Edema through Angiopoietin-Tie2 Signaling
Tadanori Mammoto et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)
Angiogenic and growth factors in gastric cancer
Susanne Blank et al.
JOURNAL OF SURGICAL RESEARCH (2015)
A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib
Subhajit Roy et al.
Anti-Cancer Agents in Medicinal Chemistry (2014)
Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer
Hanna Sallinen et al.
BMC CANCER (2014)
Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine
Anna R. Kwilas et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-kB modulation
Zijia Ren et al.
MOLECULAR CANCER (2014)
Circulating Ang-2 Mrna Expression Levels: Looking ahead to a New Prognostic Factor for NSCLC
Ana L. Coelho et al.
PLOS ONE (2014)
Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines
Benedetto Farsaci et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Clinical Significance of Serum Angiopoietin-1 in Malignant Peritoneal Mesothelioma
Koji Mikami et al.
CANCER INVESTIGATION (2013)
Modification of the Tumor Microenvironment as a Novel Target of Renal Cell Carcinoma Therapeutics
James H. Finke et al.
CANCER JOURNAL (2013)
Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
Yuhui Huang et al.
CANCER RESEARCH (2013)
Angiopoietin signaling in the vasculature
Lauri Eklund et al.
EXPERIMENTAL CELL RESEARCH (2013)
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
James W. Hodge et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Combination Therapy with Local Radiofrequency Ablation and Systemic Vaccine Enhances Antitumor Immunity and Mediates Local and Distal Tumor Regression
Sofia R. Gameiro et al.
PLOS ONE (2013)
Attacking malignant cells that survive therapy Exploiting immunogenic modulation
James W. Hodge et al.
ONCOIMMUNOLOGY (2013)
Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy
Benedetto Farsaci et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Overcoming Resistance to Antiangiogenic Therapies
Sabine Tejpar et al.
ONCOLOGIST (2012)
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Yuhui Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination
Anamika Bose et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
F. Michael Yakes et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?
Katrien De Bock et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy J. Perren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Integration of Host-Related Signatures with Cancer Cell-Derived Predictors for the Optimal Management of Anticancer Chemotherapy
Laurence Zitvogel et al.
CANCER RESEARCH (2010)
A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma
C. Tabata et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2-Neutralizing Peptibody
Angela Coxon et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels
Beverly L. Falcon et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
Hai Tao Yuan et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
James H. Finke et al.
CLINICAL CANCER RESEARCH (2008)
Leveraging the immune system during chemotherapy: Moving calreticulin to the cell surface converts apoptotic death from Silent to immunogenic
Michel Obeid et al.
CANCER RESEARCH (2007)
Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin β1-dependent adhesion to the extracellular matrix
Ok-Hee Lee et al.
MOLECULAR CANCER RESEARCH (2006)
Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling
L Eklund et al.
EXPERIMENTAL CELL RESEARCH (2006)
Expressions and clinical significances of angiopoietin-1,-2 and Tie2 in human gastric cancer
J Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
A human cytotoxic T-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1
KY Tsang et al.
CLINICAL CANCER RESEARCH (2004)
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
J Oliner et al.
CANCER CELL (2004)
Amplification of the lytic potential of effector/memory CD8+ cells by vector-based enhancement of ICAM-1 (CD54) in target cells:: implications for intratumoral vaccine therapy
DC Slavin-Chiorini et al.
CANCER GENE THERAPY (2004)
Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy
M Chakraborty et al.
JOURNAL OF IMMUNOLOGY (2003)
Tie-2 and angiopoietin-1 expression in human thyroid tumors
N Mitsutake et al.
THYROID (2002)
Mechanistic effects of autophosphorylation on receptor tyrosine kinase catalysis: Enzymatic characterization of Tie2 and phospho-Tie2
BW Murray et al.
BIOCHEMISTRY (2001)
Direct cell adhesion to the angiopoietins mediated by integrins
TR Carlson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway
I Kim et al.
ONCOGENE (2000)
分享论文
